PRA Health Sciences amplía su respuesta al COVID-19 con soluciones de farmacovigilancia para vacunas y productos terapéuticos autorizados
22 avr. 2021 11h52 HE
|
PRA Health Sciences, Inc.
RALEIGH, Carolina del Norte, April 22, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) anunció hoy la expansión de su solución de farmacovigilancia para ofrecer servicios completos...
PRA Health Sciences expande sua resposta à COVID-19 com soluções de farmacovigilância de vacinas e terapêuticas autorizadas
22 avr. 2021 11h52 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., April 22, 2021 (GLOBE NEWSWIRE) -- A PRA Health Sciences (NASDAQ: PRAH) anunciou hoje a expansão da sua solução de farmacovigilância para oferecer serviços completos de...
PRA Health Sciences meluaskan responsnya terhadap COVID-19 dengan penyelesaian farmakovigilans untuk vaksin dan terapeutik yang dibenarkan
22 avr. 2021 11h52 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., April 22, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) hari ini mengumumkan perluasan penyelesaian farmakovigilans untuk menawarkan perkhidmatan pascapemasaran penuh...
PRA Health Sciences, 승인 획득한 백신과 치료제에 대한 약물감시 솔루션 통해 코로나19 대응 능력 확대
22 avr. 2021 11h52 HE
|
PRA Health Sciences, Inc.
미국 노스캐롤라이나주 롤리, April 23, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences, (NASDAQ: PRAH))는 승인을 획득한 코로나19 백신과 치료제에 대한 종합적인 포스트 마케팅 서비스를 제공하기 위해 Real World Solutions를 통한 시판 후 안전성 평가 연구(PASS) 등 약물감시 솔루션을...
PRAヘルスサイエンス、認可済みワクチンと治療法を対象とする医薬品安全性監視ソリューションでCOVID-19への対応を拡張
22 avr. 2021 11h52 HE
|
PRA Health Sciences, Inc.
ノースカロライナ州ローリー発 , April 23, 2021 (GLOBE NEWSWIRE) -- PRAヘルスサイエンス (PRA Health Sciences) (NASDAQ: PRAH) は本日、医薬品安全性監視ソリューションの拡張を発表し、リアル･ワールド･ソリューションズ (Real World Solutions) が提供する認可後安全性試験 (PASS)...
PRA Health Sciences weitet seinen Kampf gegen COVID-19 mit Pharmakovigilanzlösungen für zugelassene Impfstoffe und Therapeutika aus
22 avr. 2021 11h52 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., April 22, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) hat heute die Erweiterung seiner Pharmakovigilanzlösungen bekanntgegeben und bietet jetzt umfassende...
PRA Health Sciences étend sa réponse à la COVID-19 avec des solutions de pharmacovigilance pour les traitements et vaccins autorisés
22 avr. 2021 11h52 HE
|
PRA Health Sciences, Inc.
RALEIGH, Caroline du Nord, 22 avr. 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ : PRAH) a annoncé aujourd'hui l'expansion de sa solution de pharmacovigilance afin d'offrir des services...
PRA Health Sciences 擴展其對冠狀病毒病的回應，並為授權的疫苗和療法提供藥物警戒解決方案
22 avr. 2021 11h52 HE
|
PRA Health Sciences, Inc.
北卡羅萊納州羅利, April 22, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) 今天宣佈擴大其藥理警戒解決方案，為授權的冠狀病毒病疫苗和治療提供整套市場營銷服務，包括由 Real World Solutions 提供的授權後安全性研究 (PASS)。PRA...
PRA Health Sciences通过针对授权疫苗和治疗药物的药物警戒解决方案扩展对新冠肺炎的响应
22 avr. 2021 11h52 HE
|
PRA Health Sciences, Inc.
北卡罗来纳州罗利市, April 22, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences（NASDAQ: PRAH）今天宣布扩展其药物警戒解决方案，为获批的新冠肺炎疫苗和治疗药物提供完整的营销后服务，包括由现实世界解决方案（Real World...
PRA Health Sciences expands its response to COVID-19 with pharmacovigilance solutions for authorized vaccines and therapeutics
21 avr. 2021 16h02 HE
|
PRA Health Sciences, Inc.
RALEIGH, N.C., April 21, 2021 (GLOBE NEWSWIRE) -- PRA Health Sciences (NASDAQ: PRAH) announced today the expansion of its pharmacovigilance solution to offer full post-marketing services for...